Back to User profile » Prof. Dr. Yuling Shi
Papers published by Prof. Dr. Yuling Shi:
Discovering Novel Biomarkers Associated with the Pathogenesis of Psoriasis: Evidence from Bioinformatic Analysis [Corrigendum]
Yang Y, Xie S, Jiang W, Tang S, Shi Y
International Journal of General Medicine 2026, 19:629571
Published Date: 8 June 2026
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in Psoriasis
Yu Y, Li B, Wang Y, Qu Z, Wang X, Jiang Y, Zhong X, Chen Y, Huang D, Bi X, Lu J, Ding Y, Gong Y, Gu J, Zhang X, Shi Y
Psoriasis: Targets and Therapy 2026, 16:609637
Published Date: 25 May 2026
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis
Dai M, Jiang Y, Xi Y, Xu L, Huang D, Wang Y, Hu Y, Yu Q, Shi Y
Psoriasis: Targets and Therapy 2025, 15:513-525
Published Date: 13 October 2025
Comorbidity Pattern in Patients with Moderate-to-Severe Plaque Psoriasis: Network Analysis of a Hospitalized Database in China
Chen W, Zheng J, Wang X, Li X, Ding Y, Peng C, Shi Y
Clinical, Cosmetic and Investigational Dermatology 2025, 18:491-501
Published Date: 28 February 2025
Disease Burden and Coping Strategies of Spouses of Patients with Psoriasis: A Qualitative Study
Wu M, Zeng S, Zhang Y, Liu Y, Li B, Yi X, Shi Y, Zhu X
Journal of Multidisciplinary Healthcare 2024, 17:1653-1662
Published Date: 17 April 2024
Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
Li Y, Lu JJ, Zhong XY, Yu YY, Yu N, Wang Y, Yi XM, Ding YF, Shi YL
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2245-2252
Published Date: 20 October 2022
Microneedle Patch Delivery of Methotrexate-Loaded Albumin Nanoparticles to Immune Cells Achieves a Potent Antipsoriatic Effect
Wang H, Zhao Z, Wu C, Tong X, Shi Y, Chen S
International Journal of Nanomedicine 2022, 17:3841-3851
Published Date: 1 September 2022
Discovering Novel Biomarkers Associated with the Pathogenesis of Psoriasis: Evidence from Bioinformatic Analysis
Yang Y, Xie S, Jiang W, Tang S, Shi Y
International Journal of General Medicine 2022, 15:2817-2833
Published Date: 11 March 2022
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
Subedi S, Gong Y, Chen Y, Shi Y
Drug Design, Development and Therapy 2019, 13:2491-2502
Published Date: 23 July 2019
Scalp metastases as first presentation of pulmonary adenocarcinomas: a case report
Yu Q, Subedi S, Tong Y, Wei Q, Xu H, Wang Y, Gong Y, Shi Y
OncoTargets and Therapy 2018, 11:6147-6151
Published Date: 21 September 2018